π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
Patients hospitalized for COVID-19 may need intensive care (e.g. mechanical...
Status
Unknown
Location
LESCURE
Start Date
2020-12-04
Trial ID
NCT04669938
Treatments Being Tested
A randomized, 2-period crossover, single-center, open-label study for viral...
Status
Completed
Location
Theravance Biopharma Investigational Site
Start Date
2021-05-04
Trial ID
NCT04681079
Treatments Being Tested
The CATARSIS study explores the use of anti-CD19 CAR T-cell therapy as a no...
Status
Recruiting
Location
Fondazione Policlinico Universitario A. Gemelli IRCCS
Start Date
2024-11-29
Trial ID
NCT06685042
Treatments Being Tested
The purpose of this study is to evaluate the safety and immune response to ...
Status
Completed
Location
Polana Canico Health Research and Training Center (CISPOC), National Institute of Health (INS) CRS
Start Date
2017-06-19
Trial ID
NCT03284710
The goal of this Diagnostic accuracy study is * To study sensitivity and s...
Status
Unknown
Location
All India Institute of Medical Sciences, New Delhi
Start Date
2022-01-27
Trial ID
NCT05636254
Treatments Being Tested
The objective of this experimental medicine study is to determine the exten...
Status
Completed
Location
NIHR Imperial Clinical Resarch Facility
Start Date
2019-03-19
Trial ID
NCT03816137
Treatments Being Tested
The purpose of the study is to see whether a single vaccination (injection)...
Status
Completed
Location
Grahame Hayton Unit, Ambrose King Centre, Royal London Hospital
Start Date
2009-11
Trial ID
NCT01071031
Treatments Being Tested
This clinical trial will be a blinded, randomised study to determine the sa...
Status
Withdrawn
Location
Royal Children's Hospital, Murdoch Children's Research Institute
Start Date
2022-05-02
Trial ID
NCT05543356
This first-in-human (FIH) phase 1 study is designed to evaluate in containe...
Status
Completed
Location
university of Antwerp - centre for the evaluation of vaccination
Start Date
2017-05-16
Trial ID
NCT03430349
Treatments Being Tested
Background: GM1 gangliosidosis is a disorder that destroys nerve cells. It...
Status
Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2019-08-19
Trial ID
NCT03952637
Treatments Being Tested